France 24: Why an Israeli company is developing an oral Covid vaccine

Oramed CEO Nadav Kidron spoke to AFP about the advantages of Oravax Medical’s oral Covid-19 vaccine: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes. Oral vaccines are particularly attractive for the developing world, because they reduce the logistical burden of immunization campaigns. Read more here.

You may also be interested

Join our mailing list

Skip to content